Cite
Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003.
MLA
Cobben, David C. P., et al. “Correspondence Re: H. Barthel et Al., 3’-Deoxy-3’-[(18)F]Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography. Cancer Res., 63: 3791-3798, 2003.” Cancer Research, vol. 63, no. 23, Dec. 2003, pp. 8558–59. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14679027&authtype=sso&custid=ns315887.
APA
Cobben, D. C. P., Elsinga, P. H., van Waarde, A., & Jager, P. L. (2003). Correspondence re: H. Barthel et al., 3’-deoxy-3’-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003. Cancer Research, 63(23), 8558–8559.
Chicago
Cobben, David C P, Philip H Elsinga, Aren van Waarde, and Pieter L Jager. 2003. “Correspondence Re: H. Barthel et Al., 3’-Deoxy-3’-[(18)F]Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography. Cancer Res., 63: 3791-3798, 2003.” Cancer Research 63 (23): 8558–59. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14679027&authtype=sso&custid=ns315887.